Expression of c-erbB-2 protein in papillary thyroid carcinomas
- PMID: 1352125
- PMCID: PMC1977754
- DOI: 10.1038/bjc.1992.177
Expression of c-erbB-2 protein in papillary thyroid carcinomas
Abstract
c-erbB-2 protein expression was investigated immunohistochemically in frozen thyroid tissue specimens from 42 patients using a polyclonal sheep antibody. c-erbB-2 immunoreactivity was detected in 12 out of 17 papillary carcinomas, while no c-erbB-2 protein immunostaining was seen in cases of follicular adenoma (five cases), follicular carcinoma (five cases) or medullary carcinoma (one case), nor in cases of non-neoplastic tissue, including normal thyroid tissue from tumour-bearing glands. RNA was extracted from 51 thyroid tissue samples from 34 of the above patients, and c-erbB-2 mRNA was analysed by slot-blot hybridisation. c-erbB-2 mRNA was detectable in all samples, but papillary carcinomas and lymph node metastases showed significantly higher levels of c-erbB-2 mRNA compared to non-neoplastic tissue. The present demonstration of positive c-erbB-2 immunostaining in papillary thyroid carcinomas is contradictory to previous findings on formalin-fixed, paraffin-embedded material, and emphasises the importance of tissue quality for c-erbB-2 protein detection.
Similar articles
-
Demonstration of a TGF-alpha-EGF-receptor autocrine loop and c-myc protein over-expression in papillary thyroid carcinomas.Int J Cancer. 1993 Aug 19;55(1):37-43. doi: 10.1002/ijc.2910550108. Int J Cancer. 1993. PMID: 8102129
-
Expression of heregulins and associations with the ErbB family of tyrosine kinase receptors in papillary thyroid carcinomas.Int J Cancer. 2000 Sep 15;87(6):763-70. doi: 10.1002/1097-0215(20000915)87:6<763::aid-ijc1>3.0.co;2-t. Int J Cancer. 2000. PMID: 10956383
-
Expression of c-erbB-2 oncoprotein in human thyroid tumours.Histopathology. 1999 Jan;34(1):60-5. doi: 10.1046/j.1365-2559.1999.00563.x. Histopathology. 1999. PMID: 9934586
-
Met protein and hepatocyte growth factor (HGF) in papillary carcinoma of the thyroid: evidence for a pathogenetic role in tumourigenesis.J Pathol. 2001 May;194(1):4-8. doi: 10.1002/path.847. J Pathol. 2001. PMID: 11329134 Review.
-
TRK oncogenes in papillary thyroid carcinoma.Cancer Treat Res. 2004;122:207-19. doi: 10.1007/1-4020-8107-3_12. Cancer Treat Res. 2004. PMID: 16209047 Review. No abstract available.
Cited by
-
C-erbB-2 immunostaining: problems with interpretation.J Clin Pathol. 1994 Sep;47(9):816-22. doi: 10.1136/jcp.47.9.816. J Clin Pathol. 1994. PMID: 7962650 Free PMC article.
-
EGF and TGF-β1 Effects on Thyroid Function.J Thyroid Res. 2011;2011:431718. doi: 10.4061/2011/431718. Epub 2011 Jun 13. J Thyroid Res. 2011. PMID: 21760980 Free PMC article.
-
Overexpression of the c-MET/HGF receptor in human thyroid carcinomas derived from the follicular epithelium.J Endocrinol Invest. 1995 Feb;18(2):134-9. doi: 10.1007/BF03349722. J Endocrinol Invest. 1995. PMID: 7629381 No abstract available.
-
Thyrocyte-specific deletion of insulin and IGF-1 receptors induces papillary thyroid carcinoma-like lesions through EGFR pathway activation.Int J Cancer. 2018 Nov 15;143(10):2458-2469. doi: 10.1002/ijc.31779. Epub 2018 Sep 22. Int J Cancer. 2018. PMID: 30070361 Free PMC article.
-
HER2 Analysis in Sporadic Thyroid Cancer of Follicular Cell Origin.Int J Mol Sci. 2016 Dec 6;17(12):2040. doi: 10.3390/ijms17122040. Int J Mol Sci. 2016. PMID: 27929428 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous